Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
01/2000
01/04/2000US6011068 Carbocyclic-alkyl secondary amines
01/04/2000US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives
12/1999
12/29/1999WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067226A1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers
12/29/1999WO1999066941A1 Herbal extract composition and method with immune-boosting capability
12/29/1999WO1999066840A1 Improvements in or relating to cardiac imaging
12/29/1999WO1999057125A3 Hygromycin a derivatives
12/29/1999EP0967214A1 Intranasal formulations for treating sexual disorders
12/29/1999EP0966448A1 Pyrazine compounds
12/29/1999EP0966304A1 Site-specific drug delivery
12/29/1999EP0966295A1 Calcareous material
12/29/1999EP0966264A1 Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant
12/29/1999EP0966258A1 Antiperspirant or deodorant composition
12/29/1999EP0966249A1 Hair coloring compositions
12/29/1999CN1239892A Use of equilenin as antioxidant
12/29/1999CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999CA2336052A1 Improvements in or relating to cardiac imaging
12/29/1999CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335580A1 Non-yellowing triazine and pyrimidine ultraviolet light absorbers
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/28/1999US6008355 Oxidizing codeine to form codeinone, converting codeinone to oxycodone in a two step one pot reaction: reacting codeinone with hydrogen peroxide in water in presence of an acid to form 14-hydroxycodeinone then hydrogenating the intermediate
12/28/1999US6008354 Protecting hydroxy group of morphine in 3 and 6 position, demethylating n-methyl on 17 position and hydrolizing the acyl group, forming 17-benzyl-3(o)protected group, oxidizing to form intermediate, hydrogenation of intermediate
12/28/1999US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999US6007829 Topically applied mixture comprising a carrier and water soluble compound(s) of free acid or salt of ethylene glycol disuccinic acid, 2,2'-oxydisuccinic acid and/or sulfosuccinic acid to increase collagen synthesis in skin cells
12/28/1999CA2037150C Retinoids
12/28/1999CA1340866C Human c3b/c4b receptor (cr1)
12/23/1999WO1999065915A1 Polymorphic clopidogrel hydrogenesulphate form
12/23/1999WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065486A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999WO1999065303A1 Composition and method for treating penile erectile dysfunction
12/23/1999WO1998054171A8 Novel form of s-omeprazole
12/23/1999CA2335134A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999CA2335112A1 Therapeutic combinations for musculoskeletal frailty
12/23/1999CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/22/1999EP0964671A1 Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining
12/22/1999EP0964667A2 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
12/22/1999EP0923382A4 Compositions of plant carbohydrates as dietary supplements
12/22/1999CN1238944A Process for preparing powdered bath lotion from liquid one of natural plant
12/22/1999CN1238943A Method for controlling sebub distribution on facial skin
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999US6004813 Il-6 activity inhibitor
12/21/1999US6004802 Oral administration of pneumococcal antigens
12/21/1999US6004582 For immediate delivery of a first active agent followed by a monitored, continuous, controlled and/or retarded delivery of a second active agent which is the same or different as the first active agent; time-release agents
12/21/1999US6004566 Bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion
12/16/1999WO1999064417A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999WO1999064028A1 Protecting neurons from ischemia
12/16/1999WO1999064026A1 A process of powder for bath from natural plants
12/16/1999CA2333332A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
12/16/1999CA2331918A1 Protecting neurons from ischemia
12/15/1999EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999EP0963195A1 Compositions containing an antifungal and a cationic agent
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999CN1238701A Process for preparing iodinated organic X-ray contrast agents
12/15/1999CN1238700A Improvents in or relating to diagnostic/therapeutic agents
12/15/1999CN1047403C Process for the preparation of large ring lactone antibiotic
12/15/1999CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/15/1999CN1047305C 可注射的组合物 Injectable compositions
12/14/1999US6001392 Antitussive drugs delivered by ion exchange resins
12/14/1999US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999US6001135 Compositions and processes for dyeing keratin fibers with cationic direct dyes, oxidation bases, and oxidizing agents
12/14/1999CA2159889C Surfactant composition containing a sodium polyoxyethylene alkyl ether sulfate surfactant and a sulphosuccinate surfactant
12/14/1999CA2155024C Genetic modification of neural stem cells
12/14/1999CA2051808C Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
12/14/1999CA1340847C Adhesin antigens
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062561A2 Gene therapy method
12/09/1999WO1999062528A1 Treatment of arthritis and other similar conditions
12/09/1999WO1999062496A1 Methods and devices for providing prolonged drug therapy
12/09/1999WO1999062471A1 Dentifrice composition containing encapsulated reactive ingredients
12/09/1999WO1999062451A1 Topical transdermal treatments
12/09/1999WO1999043285A3 Sulphonamide derivatives
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999CA2334171A1 Gene therapy method
12/09/1999CA2334144A1 Dentifrice composition containing encapsulated reactive ingredients
12/09/1999CA2333903A1 Topical transdermal treatments
12/09/1999CA2333688A1 Methods and devices for providing prolonged drug therapy
12/08/1999EP0784620B1 N-substituted piperidinyl bicyclic benzoate derivatives
12/08/1999EP0758879B1 Improved anti-dandruff shampoo
12/08/1999CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999CN1237417A Controlled drug delivery system for diltiazem
12/07/1999US5998412 Sulfamide-metalloprotease inhibitors
12/07/1999US5998364 Component B as cicatrizant
12/07/1999US5997897 Process for the production of a transdermal therapeutic system comprising the active substance 17-β-estradiol (anhydrous)
12/07/1999US5997876 Burn and wound ointment
12/02/1999WO1999061444A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/02/1999WO1999061421A1 A NOVEL VLA-4 INHIBITOR: oMePUPA-V
12/02/1999WO1999061054A1 Nicotine immunogen
12/02/1999WO1999052518A3 New treatments for nervous disorders
12/02/1999WO1999045886A3 New contraceptive kit for monotherapy
12/01/1999EP0783325B1 Contrast agent
12/01/1999CN1236609A Oxidation dyeing composition of keration fibre and dyeing method using same
11/1999
11/30/1999US5994347 For a process for treatment of anxiety and tension
11/30/1999US5994344 Bronchitis therapy
11/30/1999US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 295